Learn more

ALDERBIO HOLDINGS LLC

Overview
  • Total Patents
    277
  • GoodIP Patent Rank
    13,163
  • Filing trend
    ⇧ 11.0%
About

ALDERBIO HOLDINGS LLC has a total of 277 patent applications. It increased the IP activity by 11.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are IMMUNEXT INC, MEDAREX LLC and AMUNIX OPERATING INC.

Patent filings per year

Chart showing ALDERBIO HOLDINGS LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Latham John A 141
#2 Garcia-Martinez Leon F 139
#3 Smith Jeffrey T L 135
#4 Dutzar Benjamin H 104
#5 Mcneill Patricia Dianne 87
#6 Kovacevich Brian Robert 77
#7 Latham John 61
#8 Olson Katie 59
#9 Mitchell Danielle M 51
#10 Ojala Ethan W 41

Latest patents

Publication Filing date Title
US2019119692A1 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
US2019083665A1 Antibodies to il-6 and use thereof
US2017334986A1 Antagonists of IL-6 to raise albumin and/or lower CRP
US2017115307A1 Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies
US2017114122A1 Regulation of glucose metabolism using anti-cgrp antibodies
US2016130340A1 Dosing regimens using anti-il-6 antibodies for the treatment of rheumatoid and psoriatic arthritis
US2015259413A1 Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody
US2015132224A1 Antibodies to IL-6 and use thereof
US2016031970A1 Fermentation process for antibody production
US2014287459A1 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
US2014288272A1 Antibody purification and purity monitoring
US2014271464A1 Therapeutic use of antibodies to HGF
US2014271459A1 Antibodies to HGF and compositions containing
AU2014200210A1 Antibodies to IL-6 and use thereof
US2014079702A1 Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
AU2013204593A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
US2014004116A1 Methods of preventing or treating pain using anti-NGF antibodies
US2013344068A1 Methods of preventing inflammation and treating pain using anti-NGF compositions
US2013336975A1 Anti-NGF compositions and use thereof
US2014004115A1 Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75